Reporting Period: October 2015 – January 2019
The Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) addresses existing gaps in the prevention of HIV and other co-infections, especially tuberculosis and viral hepatitis, among people who inject drugs.
The three-year project was launched in late 2015 with core funding by the Health Programme 2014–2020 of the European Union. Twenty-two partners representing 18 EU Member States implemented the project. HA-REACT was carried out in three focus countries: Latvia, Lithuania and Hungary. However, the materials developed as part of the Joint Action will be of benefit to the entire EU.